Profile

Nancy M.P. King, J.D.Wake Forest School of Medicine

Nancy M.P. King, J.D.

Professor,

Ctr for Public Health Genomics


Contact Information

Academic: 336-716-4289 | Department: 336-716-4289

Email: nmpking@wakehealth.edu

Education & Training

  • B.A., St Johns College , 1975
  • J.D., University of North Carolina School of Law , 1980
Nancy M.P. King, J.D.

Nancy M.P. King, J.D.

Professor, Social Sciences & Health Policy
Maya Angelou Center for Health Equity
Ctr for Public Health Genomics
Institute for Regenerative Medicine
Institute for Regenerative Medicine

Research Interests

bioethics, cross(mult/tnslat/inter)discip, education outreach, education/training (all f, t,, ethics, genetics/genome

Contact Information

Academic: 336-716-4289 | Department: 336-716-4289

Email: nmpking@wakehealth.edu

Recent Publications

King NMP. Ethics in regenerative medicine and transplantation In: Orlando G, ed. Regenerative medicine applications in organ transplantation. Amsterdam; Boston: Elsevier Academic Press;2014: 977-986.

King NMP. Early-stage research: issues in design and ethics In: Hogle LF, ed. Regenerative medicine ethics: governing research and knowledge practices. New York: Springer;2014: 187-204.

King NMP, Iltis AS. Privacy and confidentiality in research In: Jennings B, ed. Bioethics. 4th ed. Farmington Hills (MI): Macmillan Reference;2014: 2503-2513.

Keys T, King NMP, Atala A. Faith in science: professional and public discourse on regenerative medicine In: Hyde MJ, Herrick JA, eds. After the genome: a language for our biotechnological future. Waco (TX): Baylor University Press;2013: 11-40.

King NMP, Robeson R. Athletes are Guinea pigs [commentary]. Am J Bioeth. 2013;13(10):13-14.

Freedman BI, Fletcher AJ, Sanghani VR, Graham A, Bailey JNC, Iltis A, King NMP. Perceptions regarding genetic testing in populations at risk for nephropathy [abstract]. J Am Soc Nephrol. 2013;24(Abstract Suppl):658A.

King NMP. There's a lot we don't know (and we ought to say so) [commentary]. Am J Bioeth. 2013;13(12):20-21.

Churchill LR, King NMP, Henderson GE. 'Why we should continue to worry about the therapeutic misconception'. J Clin Ethics. 2013;24(4):381-386.

Freedman BI, Fletcher AJ, Sanghani VR, Spainhour M, Graham AW, Russell GB, Cooke Bailey JN, Iltis AS, King NMP. Perceptions regarding genetic testing in populations at risk for nephropathy. Am J Nephrol. 2013;38(6):453-457.

Macklin R, Shepherd L, Dreger A, Asch A, Baylis F, Brody H, Churchill LR, Coleman CH, Cowan E, Dolgin J, Downie J, Dresser R, Elliott C, Epright MC, Feder EK, Glantz LH, Grodin MA, Hoffman W, Hoffmaster B, Hunter D, Iltis AS, Kahn JD, King NM, Kraft R,. The OHRP and SUPPORT--another view [letter]. N Engl J Med. 2013;369(2):e3.

Corrigan-Curay J, Cohen-Haguenauer O, O'Reilly M, Ross SR, Fan H, Rosenberg N, Somia N, King N, Freidmann T, Dunbar C, Aiuti A, Naldini L, Baum C, von Kalle C, Kiem H-P, Montini E, Bushman F, Sorrentino BP, Carrondo M,. Challenges in vector and trial design using retroviral vectors for long-term gene correction in hematopoietic stem cell gene therapy. Mol Ther. 2012;20(6):1084-1094.

King NMP. Research is care [letter]. Hastings Cent Rep. 2012;42(3):7.

King NMP, Moskop JC. Advance care planning and end-of-life decision-making In: Hester DM, Schonfeld T, eds. Guidance for healthcare ethics committees. Cambridge (UK): Cambridge University Press;2012: 80-87.

King NM. Overlapping ethical issues in cell and gene therapies [abstract]. Hum Gene Ther. 2012;23(10):A24.

Fatehi L, Wolf SM, McCullough J, Hall R, Lawrenz F, Kahn JP, Jones C, Campbell SA, Dresser RS, Erdman AG, Haynes CL, Hoerr RA, Hogle LF, Keane MA, Khushf G, King NM, Kokkoli E, Marchant G, Maynard AD, Philbert M, Ramachandran G, Siegel RA, Wickline S. Recommendations for nanomedicine human subjects research oversight: an evolutionary approach for an emerging field. J Law Med Ethics. 2012;40(4):716-750.

Henderson GE, Juengst ET, King NM, Kuczynski K, Michie M.. What research ethics should learn from genomics and society research: lessons from the ELSI Congress of 2011. J Law Med Ethics. 2012;40(4):1008-1024.

Jones JH, King NMP. Bad blood thirty years later: a Q&A with James H. Jones. J Law Med Ethics. 2012;40(4):867-872.

King NMP, Iltis AS. Introduction: research ethics: reexamining key concerns. J Law Med Ethics. 2012;40(4):865-866.

King NMP. Nanomedicine first-in-human research: challenges for informed consent. J Law Med Ethics. 2012;40(4):823-830.

Kent A, King NMP, Cohen-Haguenauer O. Toward a proportionate regulatory framework for gene transfer: a patient group-led initiative. Hum Gene Ther. 2011;22(2):126-134.

Walker RL, King NMP. Biodefense research and the U.S. regulatory structure whither nonhuman primate moral standing?. Kennedy Inst Ethics J. 2011;21(3):277-310.

King NMP, Coughlin CN, Atala A. Pluripotent stem cells: the search for the 'perfect' source. Minn J Law Sci Technol. 2011;12(2):715-730.

Hyde MJ, King NMP. Communication ethics and bioethics: an interface. Rev Commun. 2010;10(2):156-171.

Robeson R, King N. Contextualizing the character-violence equation in sports. J Study Sports Athletes Educ. 2010;4(2):123-138.

King NMP, Coughlin CN, Furth M. Ethical issues in regenerative medicine. Wake Forest Intellect Prop Law J. 2010;9(3):215-237.

Hall MA, King NMP, Perdue LH, Hilner JE, Akolkar B, Greenbaum CJ, McKeon C. Biobanking, consent, and commercialization in international genetics research: the Type 1 Diabetes Genetics Consortium. Clin Trials. 2010;7(1 Suppl):S33-S45.

Hall MA, Friedman JY, King NMP, Weinfurt KP, Schulman KA, Sugarman J. Commentary: Per capita payments in clinical trials: reasonable costs versus bounty hunting. Acad Med. 2010;85(10):1554-1556.

Coughlin CN, King NMP, Kemper K. When doctors become 'patients': advocating a patient-centered approach for health care workers in the contest of mandatory influenza vaccinations and informed consent. Wake Forest Law Rev. 2010;45(5):1551-1563.

Hall MA, King NMP. Legal methods In: Sugarman J, Sulmasy DP, eds. Methods in medical ethics. 2nd ed. Washington (DC): Georgetown University Press;2010: 127-144.

King NMP. Ethical issues in lifestyle change and adherence In: Shumaker SA, Ockene JK, Riekert KA, eds. The handbook of health behavior change. 3rd ed. New York: Springer;2009: 757-770.


King NMP. Benefits, harms, and motives in clinical research [editorial]. Hastings Cent Rep. 2009;39(4):3.

Weinfurt KP, Hall MA, King NMP, Friedman JY, Schulman KA, Sugarman J. Disclosure of financial relationships to participants in clinical research. N Engl J Med. 2009;361(9):916-621.

Schaffer R, Henderson GE, Churchill LR, King NMP, Rothschild BB, Lohser S, David AM. Parents' online portrayals of pediatric treatment and research options. J Empir Res Hum Res Ethics. 2009;4(3):73-87.

Kemper KJ, King NMP. Biomedical journals, advertising, and conflict of interest [newsletter article]. ISMTE Newsl. 2009;2(11):1-5.

King NMP. Genetic manipulation in regenerative medicine: research ethics reminders and recommendations [abstract]. Hum Gene Ther. 2009;20(11):1378-1379.

Cline J, Foster J, Strong J, Passmore L, King N, Hite R. Medical student perspectives on the role of spirituality in end-of-life decision making [abstract]. J Investig Med. 2008;56(1):442.

King NMP, Cohen-Haguenauer O. En route to ethical recommendations for gene transfer clinical trials [editorial commentary]. Mol Ther. 2008;16(3):432-438.

Vagelos R, Danforth W, Alpern R, Asghar F, Balser JR, Barnes B, Bok H, Brennan P, Carter H III, King NMP, et al. Industry funding of medical education: report of an AAMC Task Force [report]. Association of American Medical Colleges. 2008;June 2008():.

Sugarman J, Campbell CS, Citron P, Foote SB, King NMP. Medical devices policy and the humanities: examining implantable cardiac devices In: Lustig BA, Brody BA, McKenny GP, eds. Altering nature, vol II: religion, biotechnology, and public policy. New York: Springer;2008: 259-284.

King NMP, Churchill LR. Clinical research and the physician-patient relationship: the dual roles of physician and researcher In: Singer PA, Viens AM, eds. The Cambridge textbook of bioethics. New York: Cambridge University Press;2008: 214-221.

King NMP, Churchill LR. Assessing and comparing potential benefits and risks of harm In: Emanuel EJ, Grady C, Lie R, Crouch RA, Wendler D, eds. The Oxford textbook of clinical research ethics. New York: Oxford University Press;2008: 514-526.


King NMP. The ethics of genetic testing: is more always better? [commentary]. N C Med J. 2007;68(2):112-114.

Henderson GE, Churchill LR, Davis AM, Easter MM, Grady C, Joffe S, Kass N, King NMP, Lidz CW, Miller FC, et al. Clinical trials and medical care: defining the therapeutic misconception. PLoS Med. 2007;4(11):1735-1738.

King NMP, Robeson R. Athlete or guinea pig? Sports and enhancement research. Stud Ethics Law Technol. 2007;1(1):article 1.

King NMP. The glass house: assessing bioethics In: Eckenwiler LA, Cohn F, eds. The ethics of bioethics: mapping the moral landscape. Baltimore (MD): Johns Hopkins University Press;2007: 297-309.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
USNWR 2013-2014Magnet Hospital RecognitionConsumer Choice2014 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.